scispace - formally typeset
S

Shanshan Li

Researcher at Jiangxi University of Traditional Chinese Medicine

Publications -  7
Citations -  48

Shanshan Li is an academic researcher from Jiangxi University of Traditional Chinese Medicine. The author has contributed to research in topics: Medicine & Immunology. The author has an hindex of 2, co-authored 4 publications receiving 19 citations.

Papers
More filters
Journal ArticleDOI

Curcumin regulates the homeostasis of Th17/Treg and improves the composition of gut microbiota in type 2 diabetic mice with colitis

Qiuping Xiao, +9 more
- 02 Mar 2022 - 
TL;DR: Collectively, curcumin effectively alleviated colitis in mice with type 2 diabetes mellitus by restoring the homeostasis of Th17/Treg and improving the composition of the intestinal microbiota.
Journal ArticleDOI

Nitrogen-containing three-dimensional biomass porous carbon materials as an efficient enzymatic biosensing platform for glucose sensing

Baixi Shan, +10 more
- 13 Aug 2019 - 
TL;DR: In this paper, an integrated 3D-CVS electrode was fabricated by loading glucose oxidase (GOD) molecule onto a whole piece of 3D CVS electrode for a glucose biosensor, which exhibited high selectivity, good repeatability and nice stability.
Journal ArticleDOI

In Vivo Toxicity of Solasonine and Its Effects on cyp450 Family Gene Expression in the Livers of Male Mice from Four Strains.

Youbao Zhong, +6 more
- 23 Nov 2018 - 
TL;DR: Solasonine has hepatic toxicity and downregulates cyp450 genes expression at transcriptional and/or post-transcriptional levels; genetic background is an important factor which can affect the in vivo toxicity; downregulation of cyp 450 gene expression in the liver may be a clue to help understand whether or not a given strain is sensitive to solasonine.
Journal ArticleDOI

Sunitinib malate inhibits intestinal tumor development in male ApcMin/+ mice by down-regulating inflammation-related factors with suppressing β-cateinin/c-Myc pathway and re-balancing Bcl-6 and Caspase-3.

Lai Chen, +6 more
- 01 Jan 2021 - 
TL;DR: Results suggest that sunitinib malate can significantly improve the survival status and inhibit intestinal tumor development in male ApcMin/+ mice, through inhibiting inflammation-related factors, while suppressing β-cateinin/c-Myc pathway and re-balancing protein levels of Bcl-6 and Caspase-3.
Journal ArticleDOI

Bupi Yichang Pill alleviates dextran sulfate sodium-induced ulcerative colitis in mice by regulating the homeostasis of follicular helper T cells.

Youbao Zhong, +9 more
- 01 Apr 2022 - 
TL;DR: In this paper , the effects of Bupi Yichang Pill (BPYCP) on DSS-induced clinical symptoms and disease activity index (DAI) were monitored and analyzed.